Sorry EV/Rev would be ~4x not 2.2x - still massively cheaper than the majority of players in the tech space at the moment.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025